$EVOK 16 Million Patients with Gastroparesis Symptoms & Only 1 FDA Approved Drug •Estimated $3-4B prescription market •evokes nasal spray is safer, and faster acting This will be a monster opportunity for buyout after approval. Any big name company will want to corner this as fast as possible.
  • 2
2 Likes